Angelena Crown1, Nicketti Handy1, Flavio G Rocha1, Janie W Grumley2. 1. Virginia Mason Medical Center, Department of General, Thoracic and Vascular Surgery, Seattle, WA, United States. 2. Virginia Mason Medical Center, Department of General, Thoracic and Vascular Surgery, Seattle, WA, United States. Electronic address: Janie.Grumley@virginiamason.org.
Abstract
INTRODUCTION: Oncoplastic breast conserving surgery (BCS) can enhance both cosmetic and oncologic breast cancer outcomes. This study evaluates the outcomes and complications associated with oncoplastic reduction mammaplasty performed by surgical breast oncologists. METHODS: A single institution retrospective chart review of patients undergoing oncoplastic reduction mammaplasty by a surgical breast oncologist for the treatment of breast cancer. RESULTS: Seventy-one patients were identified. The average patient age was 59.6 years (range 37-77 years). Average lesion span was 31.4 mm (range 3-166 mm). Six (8.5%) patients required additional surgery to obtain adequate margins. One (1.4%) patient developed recurrent disease during the follow-up interval. No major surgical complications were observed. CONCLUSION: Oncoplastic reduction mammaplasty is associated with low rates of re-excision and complications and can be safely and effectively performed by appropriately trained surgical breast oncologists.
INTRODUCTION: Oncoplastic breast conserving surgery (BCS) can enhance both cosmetic and oncologic breast cancer outcomes. This study evaluates the outcomes and complications associated with oncoplastic reduction mammaplasty performed by surgical breast oncologists. METHODS: A single institution retrospective chart review of patients undergoing oncoplastic reduction mammaplasty by a surgical breast oncologist for the treatment of breast cancer. RESULTS: Seventy-one patients were identified. The average patient age was 59.6 years (range 37-77 years). Average lesion span was 31.4 mm (range 3-166 mm). Six (8.5%) patients required additional surgery to obtain adequate margins. One (1.4%) patient developed recurrent disease during the follow-up interval. No major surgical complications were observed. CONCLUSION:Oncoplastic reduction mammaplasty is associated with low rates of re-excision and complications and can be safely and effectively performed by appropriately trained surgical breast oncologists.
Authors: Kari M Rosenkranz; Karla Ballman; Linda McCall; Colleen McCarthy; Charlotte D Kubicky; Laurie Cuttino; Kelly K Hunt; Armando Giuliano; Kimberly J Van Zee; Bruce Haffty; Judy C Boughey Journal: Ann Surg Oncol Date: 2020-07-22 Impact factor: 5.344
Authors: Alice Lee; Richard M Kwasnicki; Hasaan Khan; Yasmin Grant; Abigail Chan; Angela E E Fanshawe; Daniel R Leff Journal: BJS Open Date: 2021-11-09
Authors: Natalie R Almeida; Fabrício P Brenelli; Cesar C Dos Santos; Renato Z Torresan; Júlia Y Shinzato; Cassio Cardoso-Filho; Giuliano M Duarte; Nicoli S de Azevedo; Luiz Carlos Zeferino Journal: JPRAS Open Date: 2021-06-06
Authors: Elizabeth A Brett; Matthias M Aitzetmüller; Matthias A Sauter; Georg M Huemer; Hans-Günther Machens; Dominik Duscher Journal: Oncotarget Date: 2018-06-12